Genetic Epilepsies with Febrile Seizures Plus (GEFS+)
Gene: SCN9AEnsemblGeneIds (GRCh38): ENSG00000169432
EnsemblGeneIds (GRCh37): ENSG00000169432
OMIM: 603415, Gene2Phenotype
SCN9A is in 13 panels
1 review
Richard Scott (Genomics England Curator)
Comment when marking as ready: Insufficient dataCreated: 8 May 2016, 6:56 p.m.
Comment on list classification: Insufficient data for diagnostic in a monogenic settingCreated: 8 May 2016, 6:56 p.m.
Details
- Mode of Inheritance
- MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
- Sources
-
- Expert Review Red
- Illumina TruGenome Clinical Sequencing Services
- Radboud University Medical Center, Nijmegen
- Phenotypes
-
- Epilepsy, generalized, with febrile seizures plus, type 7
- Febrile seizures, familial, 3B
- Familial Febrile Seizures
- Generalized Epilepsy with Febrile Seizures Plus
- OMIM
- 603415
- Clinvar variants
- Variants in SCN9A
- Penetrance
- Complete
- Panels with this gene
-
- Vascular skin disorders
- Dystonia, chorea or related movement disorder, childhood onset
- Dystonia, chorea or related movement disorder, adult onset
- Paroxysmal central nervous system disorders
- Neurodegenerative disorders, adult onset
- Hereditary ataxia, adult onset
- Familial dysautonomia
- Early onset or syndromic epilepsy
- Hereditary neuropathy
- Intellectual disability
- Pain syndromes
- Hereditary neuropathy or pain disorder
- Brain channelopathy
History Filter Activity
Gene classified by Genomics England curator
Richard Scott (Genomics England Curator)This gene has been classified as Red List (Low Evidence).
Gene classified by Genomics England curator
Richard Scott (Genomics England Curator)This gene has been classified as Red List (Low Evidence).
Added New Source
Eik Haraldsdottir (Genomics England)SCN9A was added to Genetic Epilepsy with Febrile Seizures plus (GEFS+)panel. Sources: Illumina TruGenome Clinical Sequencing Services
Added New Source
Eik Haraldsdottir (Genomics England)SCN9A was added to Genetic Epilepsy with Febrile Seizures plus (GEFS+)panel. Sources: Radboud University Medical Center, Nijmegen